| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $75.13M | $28.83M | $38.02M | $485.42M | $375.20M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $292.23M | $343.60M | $275.23M | $268.91M | $170.79M |
| R&D | $186.83M | $167.26M | $175.66M | $107.88M | $62.06M |
| SG&A | $83.23M | $72.71M | $61.00M | $55.48M | $41.85M |
| Operating Income | -$217.10M | -$314.77M | -$237.21M | $216.51M | $204.41M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | -$31.18M | -$37.54M | -$27.63M | $80.58M | $65.69M |
| Net Income | -$146.41M | -$162.86M | -$146.40M | $158.52M | $153.46M |
| EPS (basic) | -0.4900 | -0.5500 | -0.5100 | 0.5600 | 0.5600 |
| EPS (diluted) | -0.4900 | -0.5500 | -0.5100 | 0.5000 | 0.4800 |
| Shares (diluted) | $298.71M | $294.33M | $289.17M | $314.83M | $318.29M |